Press release article from our research archive:

Advanced Magnetics Announces Positive Results from Phase III Study of Ferumoxytol as an Intravenous Iron Replacement Therapeutic.

- Company Provides Update on Phase III Program -

CAMBRIDGE, Mass., Nov. 17 /PRNewswire-FirstCall/ -- Advanced Magnetics today announced positive results from a Phase III clinical trial of ferumoxytol as an intravenous (IV) iron replacement therapeutic that is being presented at the American Society of Nephrology's Renal Week 2006 Annual Meeting in San Diego, CA. A poster entitled "Ferumoxytol as Intravenous Iron Replacement Therapy in Chronic Kidney Disease (CKD) Patients Not on Dialysis -- Evaluation of Safety and Efficacy in Two Phase III Studies" is being presented today at 10:00 am PT. The study enrolled 304 non dialysis-dependent chronic kidney disease patients ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!